Clinical trial · Interventional
Ovarian Hyperstimulation Syndrome Prevention
Prophylaxis Against Ovarian Hyperstimulation Syndrome in PCOS Women
NCT06739759CI-TRIAL-00083897OHSSrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Ovarian hyperstimulation is a very hazardous complication of ICSI
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Hyper Stimulation Syndrome (OHSS) | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Antagonist protocol for IVF | Drug | — | UNRESOLVED |
| Modified Agonist protocol for IVF with additive treatments as HCQ | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- antagonist
- description
- patients with PCOS undergoing ICSI receiving antagonist protocol
- interventionNames
- Drug: Antagonist protocol for IVF
- type
- ACTIVE_COMPARATOR
- label
- Modified agonist with additives
- description
- Patients with PCOS undergoing ICSI receiving modified agonist protocol with additives
- interventionNames
- Drug: Modified Agonist protocol for IVF with additive treatments as HCQ
Primary outcomes (1)
- measure
- prevention of OHSS
- timeFrame
- within 3 weeks
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 19 Years
- Maximum age
- 42 Years
Show eligibility criteria text
Inclusion Criteria: * Women with PCOS coming for ICSI Exclusion Criteria: * Women who donnot have PCOS
References
Publications (0)
Data not yet available
No reference posted for this study.